This small molecule, 5,7-dihydroxy-4-methylcoumarin, acts as an inhibitor of human neutrophil elastase and oxidative metabolism, while also demonstrating antiplatelet aggregation and cyclooxygenase pathway inhibition in vitro. Its properties make it a candidate for research in inflammation, cardiovascular biology, and related enzymatic studies.